Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
HROW · against 463 other Healthcare companies of similar size
Ranked #317 of 464 · scores higher than 10% of peers
Bars: peers in each 10-point band of the valuation score148 peers with a valuation score of 0–9, including HROW · Click a bar to see the companies
Mainly because of its earnings yield and EBITDA yield, which are weaker than most Healthcare peers.
| Metric | HROW | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 454 reported | -3.5% | 1.3% | 31% | 30% | |
| EBITDA yieldHigher is better · 469 reported | 1.4% | 4.2% | 37% | 50% | |
| Free cash flow yieldHigher is better · 199 reported | -1.2% | -2.5% | 56% | 20% | |
| Book yieldHigher is better · 460 reported | 1.4% | 41.2% | 6% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 14.2B HKD (≈$1.8B) | 99 | 64 | |
| 1 | 12.9B HKD (≈$1.7B) | 99 | 83 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 226.3B JPY (≈$1.5B) | 99 | 77 | |
| 1 | 14.8B MXN (≈$800M) | 99 | 61 | |
| 317 | 1.4B USD | 8 | 38 | |
| 317 | 888M USD | 8 | 25 | |
| 317 | 1.5B USD | 8 | 44 | |
| 317 | 660M USD | 8 | ||
| 317 | 1.1B USD | 8 | 32 | |
| 317 | 552M USD | 8 | 39 | |
| 317 | 1.1B USD | 8 | 26 | |
| 317 | 1.2B USD | 8 | 6 | |
| 317 | 1.1B USD | 8 | 50 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score